skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,850,139  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Middle Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Sexual and preventive behaviors associated with HAV, HBV, and HPV vaccine hesitancy among men who have sex with men in France
Material Type:
Article
Add to My Research

Sexual and preventive behaviors associated with HAV, HBV, and HPV vaccine hesitancy among men who have sex with men in France

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2348845-2348845 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2348845 ;PMID: 38783608

Full text available

2
Herpes zoster in older adults: Impact on carbon footprint in the United States
Material Type:
Article
Add to My Research

Herpes zoster in older adults: Impact on carbon footprint in the United States

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2335722-2335722 [Peer Reviewed Journal]

2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2335722 ;PMID: 38698759

Full text available

3
Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania
Material Type:
Article
Add to My Research

Impact of the COVID-19 pandemic on type 2 diabetes care and factors associated with care disruption in Kenya and Tanzania

Global health action, 2024-12, Vol.17 (1), p.2345970-2345970 [Peer Reviewed Journal]

EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2345970 ;PMID: 38774927

Full text available

4
Human papillomavirus and occupational exposure: The need for vaccine provision for healthcare providers
Material Type:
Article
Add to My Research

Human papillomavirus and occupational exposure: The need for vaccine provision for healthcare providers

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2342622-2342622 [Peer Reviewed Journal]

2024 Mayo Foundation for Medical Education and Research. Published with license by Taylor & Francis Group, LLC. 2024 Mayo Foundation for Medical Education and Research ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2342622 ;PMID: 38771122

Full text available

5
Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional survey
Material Type:
Article
Add to My Research

Knowledge about, attitudes toward and acceptance and predictors of intention to receive the mpox vaccine among cancer patients in China: A cross-sectional survey

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2337157-2337157 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2337157 ;PMID: 38644633

Full text available

6
The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer
Material Type:
Article
Add to My Research

The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2355705-2355705 [Peer Reviewed Journal]

ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2024.2355705 ;PMID: 38778753

Full text available

7
Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers
Material Type:
Article
Add to My Research

Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2301631-2301631 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2301631 ;PMID: 38189360

Full text available

8
Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis
Material Type:
Article
Add to My Research

Seroprevalence of IgG antibodies against pertussis toxin in the Chinese population: A systematic review and meta-analysis

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341454-2341454 [Peer Reviewed Journal]

ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2341454 ;PMID: 38695296

Full text available

9
Hypophysitis after COVID-19 vaccination in a patient with Rathke's cleft cyst: A case report
Material Type:
Article
Add to My Research

Hypophysitis after COVID-19 vaccination in a patient with Rathke's cleft cyst: A case report

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2297455-2297455 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2297455 ;PMID: 38174857

Full text available

10
Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya
Material Type:
Article
Add to My Research

Analysis of BRCA1 germline variants (exons 5, 11 and 20) in breast cancer families from Libya

Libyan journal of medicine, 2024-12, Vol.19 (1), p.2356906-2356906 [Peer Reviewed Journal]

ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2356906 ;PMID: 38785139

Full text available

11
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study
Material Type:
Article
Add to My Research

Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2350091-2350091 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2350091 ;PMID: 38757631

Full text available

12
Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey
Material Type:
Article
Add to My Research

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2334084-2334084 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2334084 ;PMID: 38563792

Full text available

13
Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemic
Material Type:
Article
Add to My Research

Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemic

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2338953-2338953 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2338953 ;PMID: 38658178

Full text available

14
Exploring barriers to influenza vaccine uptake and recommendation among healthcare providers in the community in China: A qualitative study
Material Type:
Article
Add to My Research

Exploring barriers to influenza vaccine uptake and recommendation among healthcare providers in the community in China: A qualitative study

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2352916-2352916 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2352916 ;PMID: 38744298

Full text available

15
Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
Material Type:
Article
Add to My Research

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2310916-2310916 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2310916 ;PMID: 38369712

Full text available

16
Radiographic evaluation of teeth with pulp stones and pulp canal obliteration: characteristics, and associations with dental parameters
Material Type:
Article
Add to My Research

Radiographic evaluation of teeth with pulp stones and pulp canal obliteration: characteristics, and associations with dental parameters

Libyan journal of medicine, 2024-12, Vol.19 (1), p.2306768-2306768 [Peer Reviewed Journal]

2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1993-2820 ;EISSN: 1819-6357 ;DOI: 10.1080/19932820.2024.2306768 ;PMID: 38258544

Full text available

17
Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life
Material Type:
Article
Add to My Research

Immunogenicity and safety of Ad26.RSV.preF/RSV preF protein vaccine at predicted intermediate- and end-of-shelf-life as an evaluation of potency throughout shelf life

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2344970-2344970 [Peer Reviewed Journal]

2024 Janssen Research and Development. Published with license by Taylor & Francis Group, LLC. 2024 Janssen Research and Development ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2344970 ;PMID: 38783590

Full text available

18
Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients
Material Type:
Article
Add to My Research

Lung mucosal immunity to NTHi vaccine antigens: Antibodies in sputum of chronic obstructive pulmonary disease patients

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2343544-2343544 [Peer Reviewed Journal]

2024 GSK. Published with license by Taylor & Francis Group, LLC. 2024 GSK ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2343544 ;PMID: 38655676

Full text available

19
Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional study
Material Type:
Article
Add to My Research

Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional study

Global health action, 2024-12, Vol.17 (1), p.2325728-2325728 [Peer Reviewed Journal]

2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 1654-9716 ;ISSN: 1654-9880 ;EISSN: 1654-9880 ;DOI: 10.1080/16549716.2024.2325728 ;PMID: 38596846

Full text available

20
Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case report
Material Type:
Article
Add to My Research

Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case report

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2338644-2338644 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 1538-4047 ;EISSN: 1555-8576 ;DOI: 10.1080/15384047.2024.2338644 ;PMID: 38650446

Full text available

Results 1 - 20 of 1,850,139  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,754,226)

Refine My Results

Creation Date 

From To
  1. Before 1965  (154)
  2. 1965 To 1978  (57,056)
  3. 1979 To 1992  (182,259)
  4. 1993 To 2007  (550,172)
  5. After 2007  (1,061,169)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,849,503)
  2. magazinearticle  (546)
  3. Book Chapters  (55)
  4. Conference Proceedings  (31)
  5. Web Resources  (2)
  6. Books  (2)
  7. More options open sub menu

Subject 

  1. Science & Technology  (1,849,892)
  2. Humans  (1,849,790)
  3. Life Sciences & Biomedicine  (1,788,090)
  4. Female  (1,554,180)
  5. Male  (1,518,328)
  6. Adult  (1,226,824)
  7. Aged  (1,068,700)
  8. Biological And Medical Sciences  (578,190)
  9. Medical Sciences  (549,785)
  10. Adolescent  (370,944)
  11. Aged, 80 And Over  (365,468)
  12. Young Adult  (267,947)
  13. Retrospective Studies  (243,009)
  14. Risk Factors  (239,519)
  15. Treatment Outcome  (230,237)
  16. Surgery  (219,310)
  17. General & Internal Medicine  (193,561)
  18. Oncology  (193,242)
  19. Cardiovascular System & Cardiology  (180,322)
  20. More options open sub menu

Language 

  1. English  (1,831,248)
  2. Japanese  (274,340)
  3. Portuguese  (19,500)
  4. Spanish  (10,063)
  5. German  (6,653)
  6. French  (4,417)
  7. Russian  (1,446)
  8. Norwegian  (979)
  9. Turkish  (902)
  10. Polish  (872)
  11. Italian  (732)
  12. Korean  (566)
  13. Serbian  (379)
  14. Chinese  (365)
  15. Czech  (274)
  16. Dutch  (117)
  17. Icelandic  (106)
  18. Romanian  (88)
  19. Lithuanian  (53)
  20. Croatian  (34)
  21. More options open sub menu

Searching Remote Databases, Please Wait